Is Living Cell Technologies Limited (LVCLY) a Buy, Sell, or Hold?
OTC : LVCLY
Living Cell Technologies Limited
$0.0306 USD
$0.01 (24.39%)
- Volume
- 244
- Average Volume
- 908
- Market Capitalization
- $11.39M
- P/E Ratio
- -11.54
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.08
- Year Low
- $0.02
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $17.89
Company Overview
OTC
David Richard Hainsworth
Biotechnology
Healthcare
LVCLY
48
AU
USD
Liquidity Metrics
0.00
17.89
17.89
17.42
0.00
Sales & Valuation
-$
195.96
8.03
-16.11
-0.01
Profitability
-$0.013
-$2.1M
-1673.77%
-1673.77%
-61.85%
-65.64%
P/E Metrics
-11.54
-0.12
-0.12
Analyst Price Target & Rating
0/5
0 Analysts
%
Financial Health Scores
17.64
2/9
$3.01M
$3.19M
$178.45K
-$3.39M
Key Metrics (TTM)
$21.43M
171.14
-13.57
17.89
-61.85%
-68.93%
-8.66%
-6.21%
84 days
Company Executives
| Name | Title |
|---|---|
| Belinda Di Bartolo | Chief Operations Officer |
| Carolyn Sue | Member of Medical Advisory Board & Chief Medical Officer of NTCELL |
| James A. Mckenna | Chief Scientific Officer |
| David Richard Hainsworth | Chief Executive Officer & Executive Chairman |
| Daya Uka | Chief Financial Officer |
| Jennifer Voon | Company Secretary |
| Leah Pieris | Company Secretary |
Poll Results
No votes yet today — be the first to share your view!
About Living Cell Technologies Limited (OTC:LVCLY) Stock
Living Cell Technologies Limited (LCT) is a biotechnology company dedicated to the innovation, development, and market introduction of regenerative medical therapies. These treatments leverage naturally occurring cells with the aim of restoring physiological functions, particularly within New Zealand. A primary focus for LCT is NTCELL, a novel alginate-coated capsule currently progressing through Phase IIb clinical trials for its application in treating Parkinson's disease. The company was founded in 1987 and operates from its base in Sydney, Australia. ...
Frequently Asked Questions
-
What is the current Living Cell Technologies Limited (LVCLY) stock price?
-
Living Cell Technologies Limited(OTC:LVCLY) stock price is $0.0306 in the last trading session. During the trading session, LVCLY stock reached the peak price of $0.08 while $0.02 was the lowest point it dropped to. The percentage change in LVCLY stock occurred in the recent session was 24.39% while the dollar amount for the price change in LVCLY stock was $0.01.
-
LVCLY's industry and sector of operation?
-
The OTC listed LVCLY is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of LVCLY?
-
Belinda Di Bartolo | Chief Operations Officer
Carolyn Sue | Member of Medical Advisory Board & Chief Medical Officer of NTCELL
James A. Mckenna | Chief Scientific Officer
David Richard Hainsworth | Chief Executive Officer & Executive Chairman
Daya Uka | Chief Financial Officer -
How many employees does LVCLY have?
-
Number of LVCLY employees currently stands at 48. LVCLY operates from Tower 2, Sydney, NSW 2000, AU.
-
Link for LVCLY official website?
-
Official Website of LVCLY is: https://www.lctglobal.com
-
How do I contact LVCLY?
-
LVCLY could be contacted at phone #61 3 8689 9997 and can also be accessed through its website. LVCLY operates from Tower 2, Sydney, NSW 2000, AU.
-
How many shares of LVCLY are traded daily?
-
The average number of LVCLY shares traded daily for last 3 months was 908.
-
What is the market cap of LVCLY currently?
-
The market value of LVCLY currently stands at $11.39M with its latest stock price at $0.0306